rs142917193
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001330640.2(DENND4C):c.1399A>G(p.Ile467Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,613,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001330640.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DENND4C | ENST00000434457.7 | c.1399A>G | p.Ile467Val | missense_variant | Exon 10 of 33 | 5 | NM_001330640.2 | ENSP00000473469.1 | ||
DENND4C | ENST00000494124.2 | n.715A>G | non_coding_transcript_exon_variant | Exon 6 of 28 | 1 | ENSP00000473273.1 | ||||
DENND4C | ENST00000602925.5 | c.1399A>G | p.Ile467Val | missense_variant | Exon 10 of 32 | 5 | ENSP00000473565.1 | |||
DENND4C | ENST00000380437.8 | n.717A>G | non_coding_transcript_exon_variant | Exon 6 of 29 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152118Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000438 AC: 11AN: 251300 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461714Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727158 show subpopulations
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74300 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.691A>G (p.I231V) alteration is located in exon 6 (coding exon 6) of the DENND4C gene. This alteration results from a A to G substitution at nucleotide position 691, causing the isoleucine (I) at amino acid position 231 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at